Abstract
There is a clear need in molecular markers of prostate cancer (PC) that would specify stratification of patients into risk categories and serve as additional parameters to clinical prognostic factors. Altered DNA methylation status is one of molecular processes that occur during PC development. The gene methylation status may be evaluated in laboratory diagnostics by a PCR approach known as means of methylation-sensitive high resolution melting (MS-HRM) curve analysis. This method is particularly promising due to minimal amounts of DNA required for analysis (10 ng). To date, numerous data based on the use of Infinium HumanMethylation450 BeadChip (HM450) technology have been accumulated on DNA methylation in PC samples. However, it remains unclear whether the MS-HRM results are consistent with chip hybridization data. The aim of this study was to perform the comparative analysis of the diagnostic informativeness of MS-HRM and HM450 chip hybridization methods in determination of the methylation status of three genes GSTP1, APC, and RASSF1 in samples obtained from PC patients. The study has shown that using the MS-HRM method it is possible to discriminate PC tumor samples from samples of histologically unaltered prostate tissue by analyzing the methylation status of each gene. Analysis of chip hybridization data confirmed the results obtained by MS-HRM. Differences between tumor tissue and histologically intact tissue obtained from each PC patient in the methylation levels of GSTP1, APC, and RASSF1, determined by MS-HRM or chip hybridization were consistent with each other. Thus, the assessment of the methylation level of gene GSTP1, APC, and RASSF1 using MS-HRM can become the basis for the development of a laboratory test, the specifying diagnosis of prostate cancer.
Similar content being viewed by others
References
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., and Bray, F., Int. J. Cancer, 2015, vol. 136, no. 5, pp. E359–E386. doi 10.1002/ijc.29210
Kaprin, A.D., Starinskii, V.V., and Petrova, G.V., Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2015 gody (The State of Oncological Care for the Population of Russian Federation in 2015), Moscow: Hertsen Moscow Oncology Research Institute, 2016.
Humphrey, P.A., Moch, H., Cubilla, A.L., Ulbright, T.M., and Reuter, V.E., Eur. Urol., 2016, vol. 70, no. 1, pp. 106–119. doi 10.1016/j.eururo.2016.02.028
Van Neste, L., Partin, A. W., Stewart, G.D., Epstein, J.I., Harrison, D.J., and Van Criekinge, W., Prostate, 2016, vol. 76, no. 12, pp. 1078–1087. doi 10.1002/pros.23191
Hanahan, D. and Weinberg, R.A., Cell, 2011, vol. 144, no. 5, pp. 646–674. http://dx.doi.org/doi 10.1016/j.cell.2011.02.013
Berdasco, M. and Esteller, M., Dev. Cell, 2010, vol. 19, no. 5, pp. 698–711. doi 10.1016/j.devcel.2010.10.005
Rybicki, B.A., Rundle, A., Kryvenko, O.N., Mitrache, N., Do, K.C., Jankowski, M., Chitale, D.A., Trudeau, S., Belinsky, S.A., and Tang, D., Int. J. Cancer, 2016, vol. 138, no. 12, pp. 2884–2893. doi 10.1002/ijc.30038
Yang, B., Bhusari, S., Kueck, J., Weeratunga, P., Wagner, J., Leverson, G., Huang, W., and Jarrard, D.F., Neoplasia, 2013, vol. 15, vol. 4, pp. 399–408. doi 10.1593/neo.13280
Kobayashi, Y., Absher, D.M., Gulzar, Z.G., Young, S.R., McKenney, J.K., Peehl, D.M., Brooks, J.D., Myers, R.M., and Sherlock, G., Genome Res., 2011, vol. 21, no. 7, pp. 1017–1027. doi 10.1101/gr.119487.110
Mahapatra, S., Klee, E.W., Young, C.Y., Sun, Z., Jimenez, R.E., Klee, G.G., Tindall, D.J., and Donkena, K.V., Clin. Cancer Res., 2012, vol. 18, no. 10, pp. 2882–2895. doi 10.1158/1078–0432.CCR-11-2090
Kim, J.W., Kim, S.T., Turner, A.R., Young, T., Smith, S., Liu, W., Lindberg, J., Egevad, L., Gronberg, H., Isaacs, W.B., and Xu, J., PLoS One, 2012, vol. 7, no. 10, e48455. doi 10.1371/journal. pone.0048455
Haldrup, C., Mundbjerg, K., Vestergaard, E.M., Lamy, P., Wild, P., Schulz, W.A., Arsov, C., Visakorpi, T., Borre, M., Høyer, S., Ørntoft, T.F., and Sørensen, K.D., J. Clin. Oncol., 2013, vol. 31, no. 26, pp. 3250–3258. doi 10.1200/JCO.2012.47.1847
Geybels, M.S., Zhao, S., Wong, C.J., Bibikova, M., Klotzle, B., Wu, M., Ostrander, E.A., Fan, J.B., Feng, Z., and Stanford, J.L., Prostate, 2015, vol. 75, no. 16, pp. 1941–1950. doi 10.1002/pros.23093
Hessels, D. and Schalken, J.A., Asian J. Androl., 2013, vol. 15, no. 3, pp. 333–339. doi 10.1038/aja.2013.6
Henrique, R., Ribeiro, F.R., Fonseca, D., Hoque, M.O., Carvalho, A.L., Costa, V.L., Pinto, M., Oliveira, J., Teixeira, M.R., Sidransky, D., and Jerónimo, C., Clin. Cancer Res., 2007, vol. 13, no. 20, pp. 6122–6129. doi 10.1158/1078-0432.CCR-07-1042
Litovkin, K., Van Eynde, A., Joniau, S., Lerut, E., Laenen, A., Gevaert, T., Spahn, M., Kneitz, B., Gramme, P., Helleputte, T., Isebaert, S., Haustermans, K., and Helleputte, T., PLoS One, 2015, vol. 10, no. 6, e0130651. doi 10.1371/journal.pone.0130651
Babalyan, K.A., Sultanov, R., Generozov, E.V., Zakharzhevskaya, N.B., Sharova, E.I., Peshkov, M.N., Vasil’ev, A.O., Govorov, A.V., Pushkar’, D.Yu., Prilepskaya, E.A., Danilenko, S.A., Babikova, E.A., Larin, A.K., and Govorun, V.M., Vopr. Onkol., 2016, no. 1, pp. 122–132.
Wojdacz, T.K., Dobrovic, A., and Hansen, L.L., Nat. Protoc., 2008, vol. 3, no. 12, pp. 1903–1908. doi 10.1038/nprot.2008.191
Spitzwieser, M., Holzweber, E., Pfeiler, G., Hacker, S., and Cichna-Markl, M., Breast Cancer Res., 2015, vol. 17, p. 125. doi 10.1186/s13058-015-0637-5
Migheli, F., Stoccoro, A., Coppede, F., Omar, W.A.W., Failli, A., Consolini, R., Seccia, M., Spisni, R., Miccoli, P., Mathers, J.C., and Migliore, L., PLoS One, 2013, vol. 8, no. 1, e52501. doi 10.1371/journal. pone.0052501
Assenov, Y., Müller, F., Lutsik, P., Walter, J., Lengauer, T., and Bock, C., Nat. Methods, 2014, vol. 11, no. 11, pp. 1138–1140. doi 10.1038/nmeth.3115
Teschendorff, A.E., Marabita, F., Lechner, M., Bartlett, T., Tegner, J., Gomez-Cabrero, D., and Beck, S., Bioinformatics, 2013, vol. 29, no. 2, pp. 189–196. doi 10.1093/bioinformatics/bts680
Triche, T.J., Weisenberger, D.J., Van Den Berg, D., Laird, P.W., and Siegmund, K.D., Nucleic Acids Res., 2013, vol. 41, no. 7, e90. doi 10.1093/nar/gkt090
Bilic-Zulle, L., Biochem. Med. (Zagreb), 2011, vol. 21, no. 1, pp. 49–52. PMID: 22141206
Giavarina, D., Biochem. Med. (Zagreb), 2015, vol. 25, no. 2, pp. 141–151. doi 10.11613/BM.2015.015
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.O. Skorodumova, K.A. Babalyan, R. Sultanov, A.O. Vasiliev, A.V. Govorov, D.Y. Pushkar, E.A. Prilepskaya, S.A. Danilenko, E.V. Generozov, A.K. Larin, E.S. Kostryukova, E.I. Sharova, 2017, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Skorodumova, L.O., Babalyan, K.A., Sultanov, R. et al. The methylation status of GSTP1, APC, and RASSF1 genes in human prostate cancer samples: Comparative analysis of diagnostic informativeness of MS-HRM and hybridization on the Illumina Infinium HumanMethylation450 BeadChip. Biochem. Moscow Suppl. Ser. B 11, 194–201 (2017). https://doi.org/10.1134/S199075081702007X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S199075081702007X